Startseite>>Signaling Pathways>> Others>> Estrogen Receptor/ERR>>Endoxifen E-isomer

Endoxifen E-isomer

Katalog-Nr.GC35988

Das Endoxifen-E-Isomer (E-Endoxifen), ein E-Isomer von Endoxifen, ist eine Verunreinigung in der Endoxifen-Z-Isomer-Arzneimittelsubstanz. Endoxifen E-Isomer zeigt antiöstrogene Wirkungen.

Products are for research use only. Not for human use. We do not sell to patients.

Endoxifen E-isomer Chemische Struktur

Cas No.: 114828-90-9

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
306,00 $
Auf Lager
5mg
278,00 $
Auf Lager
10mg
417,00 $
Auf Lager
50mg
1.391,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Endoxifen E-isomer is the E-isomer of (Z)-Endoxifen. (Z)-Endoxifen, an active metabolite generated via actions of CYP3A4/5 and CYP2D6, is a more potent selective estrogen receptor modulator (SERM) than Tamoxifen.

Endoxifen exists as the potently anti-estrogenic (Z)-isomer and the lesser known (E)-isomer. It is assumed that (E)-Endoxifen, structurally related to (E)-4-OH-tamoxifen, have similar pharmacological properties. The (E)-isomer is an impurity in (Z)-Endoxifen drug substance and increases under certain storage conditions. (E)-Endoxifen is identified as the primary degradant[1].

[1]. Elkins P, et al. Characterization of the isomeric configuration and impurities of (Z)-Endoxifen by 2D NMR, high resolution LC-MS, and quantitative HPLC analysis. J Pharm Biomed Anal. 2014 Jan;88:174-9.

Bewertungen

Review for Endoxifen E-isomer

Average Rating: 5 ★★★★★ (Based on Reviews and 5 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Endoxifen E-isomer

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.